Alinidine pharmacokinetics following acute and chronic dosing (Q42008683)

15 October 2017

Alinidine pharmacokinetics following acute and chronic dosing (English)

1 reference

15 October 2017

1 reference

Harron DW

1

1 reference

15 October 2017

Arndts D

series ordinal

2

1 reference

15 October 2017

Shanks RG

series ordinal

3

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 June 1982

1 reference

British Journal of Clinical Pharmacology

15 October 2017

1 reference

15 October 2017

13

1 reference

15 October 2017

6

1 reference

15 October 2017

821-827

1 reference

Proof of the linearity of the pharmacokinetics of alinidine in man.

15 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402022

N-Allyl-derivative of clonidine, a substance with specific bradycardic action at a cardiac site

5 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402022

Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine

5 June 2018

1 reference

12 December 2020

Model building in pharmacokinetics/Part II: Generalized theoretical presentation of complete integration of linear compartment models of optional structure (author's transl)

1 reference

12 December 2020

Cardiovascular actions of N-allyl-clonidine (ST 567), a substance with specific bradycardic action

1 reference

12 December 2020

Alinidine reduces heart-rate without blockade of beta-adrenoceptors

1 reference

12 December 2020

10.1111/J.1365-2125.1982.TB01873.X

Identifiers

DOI

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

7093113

1 reference